Cytosorbents Corp (CTSO) stock
CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$5.57+1.05 (+23.12%)
Close on Nov 18, 2026Market cap $349.72MP/E –Yield –
Cytosorbents free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Cytosorbents's free cash flow for the twelve months ending Sep 30, 2026 was -$6.99M. For fiscal 2025 it was -$12.54M. The highest annual figure on record is -$2.62M in fiscal 2010.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$12.54M | – |
| FY2024 | Dec 31, 2024 | -$14.71M | – |
| FY2023 | Dec 31, 2023 | -$22.19M | – |
| FY2022 | Dec 31, 2022 | -$34.32M | – |
| FY2021 | Dec 31, 2021 | -$17.65M | – |
| FY2020 | Dec 31, 2020 | -$6.32M | – |
| FY2019 | Dec 31, 2019 | -$17.46M | – |
| FY2018 | Dec 31, 2018 | -$11.51M | – |
| FY2017 | Dec 31, 2017 | -$7.45M | – |
| FY2016 | Dec 31, 2016 | -$6.87M | – |
| FY2015 | Dec 31, 2015 | -$9.45M | – |
| FY2014 | Dec 31, 2014 | -$6.43M | – |
| FY2013 | Dec 31, 2013 | -$3.53M | – |
| FY2012 | Dec 31, 2012 | -$3.64M | – |
| FY2011 | Dec 31, 2011 | -$3.86M | – |
| FY2010 | Dec 31, 2010 | -$2.62M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$287.00K | – |
| Q2 FY2026 | Jun 30, 2026 | -$597.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.17M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.93M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.59M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.55M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.47M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.41M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.62M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.81M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.87M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.50M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.35M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.72M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.62M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.55M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.37M | – |
| Q2 FY2022 | Jun 30, 2022 | -$12.56M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.83M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.02M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.03M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.82M | -252.1% |
| Q1 FY2021 | Mar 31, 2021 | -$2.77M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.22M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.51M | – |
| Q2 FY2020 | Jun 30, 2020 | $1.86M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.44M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.26M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.33M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.33M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.53M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.88M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.66M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.52M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.45M | – |
| Q4 FY2017 | Dec 31, 2017 | -$820.21K | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.53M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.04M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.06M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.06M | – |
See a number that looks wrong?